Literature DB >> 17491594

Regulation of c-Src by binding to the PDZ domain of AF-6.

Gerald Radziwill1, Andreas Weiss, Jochen Heinrich, Martin Baumgartner, Prisca Boisguerin, Koji Owada, Karin Moelling.   

Abstract

c-Src is a tightly regulated non-receptor tyrosine kinase. We describe the C-terminus of c-Src as a ligand for a PDZ (postsynaptic density 95, PSD-95; discs large, Dlg; zonula occludens-1, ZO-1) domain. The C-terminal residue Leu of c-Src is essential for binding to a PDZ domain. Mutation of this residue does not affect the intrinsic kinase activity in vitro, but interferes with c-Src regulation in cells. As a candidate PDZ protein, we analysed AF-6, a junctional adhesion protein. The AF-6 PDZ domain restricts the number of c-Src substrates, whereas knockdown of AF-6 has the opposite effect. Binding of c-Src to the AF-6 PDZ domain interferes with phosphorylation of c-Src at Tyr527 by the C-terminal kinase, and reduces c-Src autophosphorylation at Tyr416, resulting in a moderately activated c-Src kinase. Unphosphorylated Tyr527 allows binding of c-Src to AF-6. This can be overcome by overexpression of CSK or strong activation of c-Src. c-Src is recruited by AF-6 to cell-cell contact sites, suggesting that c-Src is regulated by a PDZ protein in special cellular locations. We identified a novel type of c-Src regulation by interaction with a PDZ protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17491594      PMCID: PMC1888668          DOI: 10.1038/sj.emboj.7601706

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Induction of putative tumor-suppressing genes in Rat-1 fibroblasts by oncogenic Raf-1 as evidenced by robot-assisted complex hybridization.

Authors:  J Heinrich; M Bosse; H Eickhoff; W Nietfeld; R Reinhardt; H Lehrach; K Moelling
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

2.  WW domain sequence activity relationships identified using ligand recognition propensities of 42 WW domains.

Authors:  Livia Otte; Urs Wiedemann; Brigitte Schlegel; José Ricardo Pires; Michael Beyermann; Peter Schmieder; Gerd Krause; Rudolf Volkmer-Engert; Jens Schneider-Mergener; Hartmut Oschkinat
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

Review 3.  Nectin and afadin: novel organizers of intercellular junctions.

Authors:  Yoshimi Takai; Hiroyuki Nakanishi
Journal:  J Cell Sci       Date:  2003-01-01       Impact factor: 5.285

Review 4.  Role of Src expression and activation in human cancer.

Authors:  R B Irby; T J Yeatman
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

Review 5.  Selected glimpses into the activation and function of Src kinase.

Authors:  J D Bjorge; A Jakymiw; D J Fujita
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

6.  The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.

Authors:  B Boettner; E E Govek; J Cross; L Van Aelst
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells.

Authors:  Yan-Hua Chen; Qun Lu; Daniel A Goodenough; Beverly Jeansonne
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

Review 8.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

9.  Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.

Authors:  C Kühne; D Gardiol; C Guarnaccia; H Amenitsch; L Banks
Journal:  Oncogene       Date:  2000-11-30       Impact factor: 9.867

Review 10.  Src in cancer: deregulation and consequences for cell behaviour.

Authors:  Margaret C Frame
Journal:  Biochim Biophys Acta       Date:  2002-06-21
View more
  7 in total

1.  c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site.

Authors:  Martin Baumgartner; Gerald Radziwill; Mihaela Lorger; Andreas Weiss; Karin Moelling
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

2.  Crystal structure of afadin PDZ domain-nectin-3 complex shows the structural plasticity of the ligand-binding site.

Authors:  Yoshie Fujiwara; Natsuko Goda; Tomonari Tamashiro; Hirotaka Narita; Kaori Satomura; Takeshi Tenno; Atsushi Nakagawa; Masayuki Oda; Mamoru Suzuki; Toshiaki Sakisaka; Yoshimi Takai; Hidekazu Hiroaki
Journal:  Protein Sci       Date:  2015-01-13       Impact factor: 6.725

3.  MotifAnalyzer-PDZ: A computational program to investigate the evolution of PDZ-binding target specificity.

Authors:  Jordan Valgardson; Robin Cosbey; Paul Houser; Milo Rupp; Raiden Van Bronkhorst; Michael Lee; Filip Jagodzinski; Jeanine F Amacher
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

4.  ODAM Expression Inhibits Human Breast Cancer Tumorigenesis.

Authors:  Daniel P Kestler; James S Foster; Charles T Bruker; John W Prenshaw; Stephen J Kennel; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Breast Cancer (Auckl)       Date:  2011-04-28

5.  Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.

Authors:  Swadesh K Das; Sujit K Bhutia; Upneet K Sokhi; Belal Azab; Zhao-Zhong Su; Habib Boukerche; Talha Anwar; Erika L Moen; Devasis Chatterjee; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2012-10-11       Impact factor: 12.701

6.  R-Ras controls axon branching through afadin in cortical neurons.

Authors:  Nariaki Iwasawa; Manabu Negishi; Izumi Oinuma
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

7.  KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.

Authors:  Syed M Ahmed; Brigitte L Thériault; Maruti Uppalapati; Catherine W N Chiu; Brenda L Gallie; Sachdev S Sidhu; Stéphane Angers
Journal:  J Cell Biol       Date:  2012-12-03       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.